Global Aortic Stent Grafts Market Size to Reach USD 3.12 Billion in 2032 | Emergen Research

Increasing prevalence of aortic aneurysm is a key factor driving Aortic Stent Grafts market revenue growth

Vancouver, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The global market size for aortic stent grafts was valued at USD 2.15 Billion in 2022. According to the latest analysis conducted by Emergen Research, it is projected to maintain a consistent revenue Compound Annual Growth Rate (CAGR) of 3.7% throughout the forecast period. The notable upsurge in the prevalence of cardiovascular conditions, notably aortic aneurysms, stands out as a pivotal catalyst propelling the growth of market revenue.

Aortic aneurysms tend to occur in approximately 5-10 cases per 100,000 individuals in the United States. This condition is more frequently observed in males aged 60 and above. While aortic aneurysms in themselves may not directly lead to fatalities, complications such as dissections or ruptures contribute to an estimated 15,000 deaths annually. A variety of surgical options are available, categorized as open and endovascular procedures, contingent upon the aneurysm type and whether a relatively straightforward repair or a more intricate replacement is necessitated.

You Can Download Free Sample PDF Copy Of This Report @

In surgical interventions, the affected segment of the aorta is either substituted with a graft or stabilized using a stent. This approach offers structural reinforcement to the aneurysm, consequently mitigating the risk of subsequent complications.

Nonetheless, the presence of potential endoleaks and various associated complications stands as a significant inhibiting factor that could impede the progression of market revenue. The primary drawback associated with Endovascular Aneurysm Repair (EVAR) procedures is the elevated likelihood of complications emerging post-procedure, often necessitating subsequent interventions. Consequently, it is widely recommended by experts to maintain an ongoing regimen of imaging surveillance subsequent to the repair process.

Complications can stem from both systemic factors and issues directly related to the endograft device itself. Notable among these complications are instances of endoleaks, migration or collapse of the endograft, the occurrence of kinks and/or stenosis in an endograft limb, and the potential development of graft infections. These issues underline the complexities that can arise in relation to the device's functionality and compatibility within the body.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

Scope of Research

Report DetailsOutcome
Market Size in 2022USD 2.15 Billion
CAGR (2023–2032)3.7%
Revenue Forecast To 2032USD 3.12 Billion
Base Year For Estimation2022
Historical Data2019–2021
Forecast Period2023–2032
Quantitative UnitsRevenue in USD Billion and CAGR in % from 2023 to 2032
Report CoverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments CoveredProduct, end-use, and region
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country ScopeU.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa
Key Companies ProfiledMedtronic plc, W. L. Gore & Associates, Inc., Cook Group Limited, Endologix LLC, Terumo Corporation, Lifetech Scientific, Microport Scientific Corporation, Cordis, Beckton Dickinson and Company, and Lombard Medical
Customization Scope10 hours of free customization and expert consultation

Major Companies and Competitive Landscape

The global aortic stent grafts market is fragmented, with several medium and large-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing new aortic stent grafts devices. Some major players included in the global aortic stent grafts market report are:

  • Medtronic plc
  • W. L. Gore & Associates, Inc.
  • Cook Group Limited
  • Endologix LLC
  • Terumo Corporation
  • Lifetech Scientific
  • Microport Scientific Corporation
  • Cordis
  • Beckton Dickinson and Company (BD)
  • Lombard Medical

Strategic Development

  • In September 2022, Getinge established a supply agreement with Medtronic, which has just gained CE mark for the Radiant covered stent, the first covered stent indicated for chimney endovascular aneurysm repair (ChEVAR). The Radiant covered stent is a Medtronic-distributed private labelled Advanta V12 balloon expandable covered stent manufactured by Getinge.
  • In December 2021, Terumo Aortic announced the launch of the Aortic Balloon in the U.S., as well as the first commercial case. When employing TREO and RELAY stent-grafts in endovascular aortic repair, the device supports physicians in expanding the aorta. The Aortic Balloon is a low-profile device with a 10 F rating that provides great inflation control and the widest balloon diameter range (up to 50mm).

Direct Order Can Be Placed Through This Link [Exclusive Copy] @

Some Key Highlights From the Report

  • The abdominal aortic stent graft segment accounted for largest revenue share in the global aortic stent grafts market in 2022. This is due to rapid advancements in technology and improved stent graft designs, which has led to better outcomes and improved eligibility criteria for patients. Endovascular stent graft repair of Abdominal Aortic Aneurysm (AAA) has advanced rapidly since its introduction. EVAR of AAA has been confirmed as a successful alternative to open surgery owing to its decreased invasiveness, lower morbidity and mortality, and lower overall treatment cost.
  • The hospitals segment is expected to register steadily fast revenue growth rate in the global aortic stent grafts market during the forecast period. This is because hospitals are carrying out a significant volume of aortic aneurysm repair procedures, catering to both abdominal and thoracic aortic aneurysms. This trend is driven by large number of cases of aortic aneurysms and rising preference for Minimally Invasive (MI) procedures instead of open repair methods.
  • The North America market is expected to account for largest revenue share in the global aortic stent grafts market over the forecast period. This is due to increasing prevalence of cardiovascular disorders and presence of better and advanced healthcare infrastructure. Moreover, technological advancements in minimally invasive surgeries is also expected to drive market revenue growth in this region during the forecast period.

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends @

Emergen Research has segmented the global aortic stent grafts market on the basis of product, end-use, and region:

  • Product Outlook (Revenue, USD Billion; 2019-2032)
    • Abdominal Aortic Stent Graft
    • Thoracic Aortic Stent Graft
  • End-Use Outlook (Revenue, USD Billion; 2019-2032)
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers (ASCs)
  • Regional Outlook (Revenue, USD Billion; 2019–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. UK
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of Middle East & Africa

Curated Reports You Shouldn't Miss: Dive In Now!

Follicular Lymphoma Treatment Market by treatment (Monoclonal Antibodies, Targeted therapy, Chemotherapy), By route of administration (Oral, Parenteral), and By End Use (Hospitals, Oncology Centers) Forecasts to 2027

Pediatric Psoriasis Market Analysis By Type (Plaque, Guttate, Pustular, Inverse, Erythrodermic, Mucosal/oral, Nail, Napkin or diaper, Photosensitive, Flexural), By Treatment (Topical therapy, Oral, Injections), By End Use (Hospitals, Specialty Clinics, Ambulatory Care Centers, Research Organizations), By Region, Forecasts to 2027

Pulse Oximeter Market, By Product Type (Handheld Devices, Fingertip, Tabletop, Wearable), By Technology (Smart and Conventional), By End-Use (Hospitals and Healthcare & Diagnostic Centers), and By Region Forecast to 2030

Transcatheter Mitral Valve Implantation Market Analysis, By Product (Mechanical Valves & Bioprosthetic Tissue (Biological) Valves), By Application (Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation), By End Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), Forecasts to 2027

mHealth Market, By Platform (Mobile Apps and Wearable Devices), By Application (Remote Monitoring and Disease and Epidemic Outbreak Tracking), By End-Use (Healthcare Providers and Hospitals and Clinics), and By Region Forecast to 2030

Advanced Wound Care Market By Product Type (Moist Wound Dressing, Wound Therapy Devices), By Wound Type (Surgical Wounds, Ulcers, Burns, Traumatic Wounds), By End-User (Hospitals and Clinics, Home Care Settings), and By Region, Forecasts to 2027

Alternative Proteins Market, By Source (Plant-based, Insect-based, Microbial-based) By Application (Meat Substitutes, Dairy Alternatives, Bakery, Nutrient Supplement), By Form (Dry Form, Wet Form), and By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Explore Our Blogs and Insights Section:

Read our Press Release @

Contact Data